Estudo de bioequivalência entre duas formulações de ciprofibrato 100 mg comprimidos em voluntários sadios após administração de dose única

César, Isabela Costa; Teixeira, Leonardo de Souza; Mundim, Iram Moreira; Bellorio, Karini Bruno; Abreu, Fernanda Crunivel de; Souza, Weidson Carlo de; Fernandes, Christian; Pianetti, Gerson Antônio; Morais, Douglas Costa; Lima, Leila Gonçalves.
RBM rev. bras. med ; 70(10)out. 2013.
Artigo em Português | LILACS | ID: lil-704886

Documentos relacionados

  1. Batch Selection via In Vitro/In Vivo Correlation in Pharmacokinetic Bioequivalence Testing.
  2. Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations.
  3. Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers
  4. Comparação da bioequivalência entre duas formulações de montelucaste de sódio 10 mg comprimidos revestidos em voluntários sadios após a administração de dose única
  5. Development of An HPLC Method for the Determination of Mesalazine in Human Plasma by Fluorimetric Derivatization and Application to A Prototype Pharmacokinetic Study.
  6. Quick and simple LC-MS/MS method for the determination of simvastatin in human plasma: application to pharmacokinetics and bioequivalence studies
  7. Checking distributional assumptions for pharmacokinetic summary statistics based on simulations with compartmental models.
  8. Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations.
  9. Sensitivity of indirect metrics for assessing "rate" in bioequivalence studies--moving the "goalposts" or changing the "game".
  10. A new PK equivalence test for a bridging study.